摘要
本研究的目的是探讨边缘活化剂结构对新型变形脂质体性质的影响,渗透促进剂的囊泡(PEV),能够将药物输送至皮肤。渗透促进剂的囊泡(PEV)的制备是通过测试五种不同的两性渗透促进剂,其可作为边缘活化剂,具有双层结构,含有大豆磷脂酰胆碱和油酸。渗透促进剂含有相同的亲脂性的尾部(一个或多个C8-C10碳链)和不同的亲水性头部。制备传统磷脂脂质体作为对照。利多卡因被选为模型药物。根据渗透剂的使用情况,可选择液体状和凝胶状的PEVs。囊泡体系的特征可通过测量粒度分布, Zeta电位,结合率等,并在90天内监测这些参数。进行加速老化试验检查分散体的稳定性。采用透射电子显微镜(TEM),SAXS,流变模型与可变形性研究评估边缘活化剂的不同性质对PEVs特点的影响。观察具有脂质双层结构的高亲脂性渗透剂和较高稳定性及弹性的PEVs之间的相互作用。通过猪皮体外实验证实,与商业的丙胺卡因乳剂比较,高亲脂性渗透促进剂制备的PEV利多卡因可作为潜在载体。
关键词: 脂质体,渗透剂,利多卡因,流变学,皮肤渗透,丙胺卡因乳剂
图形摘要
Current Drug Targets
Title:Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery?
Volume: 16 Issue: 13
Author(s): Carla Caddeo, Maria Manconi, Chiara Sinico, Donatella Valenti, Christian Celia, Maura Monduzzi and Anna Maria Fadda
Affiliation:
关键词: 脂质体,渗透剂,利多卡因,流变学,皮肤渗透,丙胺卡因乳剂
摘要: The aim of this study was to elucidate the influence of the edge activator structure on the properties of novel deformable liposomes, Penetration Enhancer-containing Vesicles (PEVs), capable of delivering drugs to the skin. The PEVs were prepared by testing five different amphiphilic penetration enhancers as edge activators in the bilayer composition, together with soy phosphatidylcholine and oleic acid. The penetration enhancers contained the same lipophilic tail (one or more C8-C10 carbon chains) and different hydrophilic heads. Conventional phospholipid liposomes were prepared and used as a control. Lidocaine was chosen as a model drug. Liquid and gelified PEVs were obtained, depending on the penetration enhancer used. The vesicular systems were characterized by measuring size distribution, zeta potential, incorporation efficiency, and monitoring these parameters over 90 days. Accelerated ageing tests were also performed to check the stability of the dispersions. The effects of the different nature of the edge activator on the features of the obtained PEVs were assessed by TEM, SAXS and WAXS, rheological and deformability studies. Higher interactions of the most lipophilic penetration enhancers with the lipid bilayers and a consequent higher stability and elasticity of the obtained PEVs were observed. In vitro experiments through pig skin confirmed the superior potential as carriers for lidocaine of the PEVs prepared with the most lipophilic penetration enhancers, even in comparison with commercial EMLA cream.
Export Options
About this article
Cite this article as:
Carla Caddeo, Maria Manconi, Chiara Sinico, Donatella Valenti, Christian Celia, Maura Monduzzi and Anna Maria Fadda , Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery?, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450115666140804224024
DOI https://dx.doi.org/10.2174/1389450115666140804224024 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers